<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Genetic alteration, including genomic instability, is an ultimate step toward the malignant process </plain></SENT>
<SENT sid="1" pm="."><plain>One approach to delineating replication errors in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells is to determine the alterations of microsatellites, which are short, repeated nucleotide sequences existing throughout the genomes </plain></SENT>
<SENT sid="2" pm="."><plain>We used a fluorescent system to assess microsatellite changes in seven loci (D2S123, D3S643, D5S107, LPL, D17S261, TP53, and D18S34) of 73 consecutive patients with various hematological <z:hpo ids='HP_0002664'>neoplasias</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>De novo <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> patients had a low frequency (&lt;1%) of microsatellite alterations at each locus, and none of them demonstrated multiple microsatellite changes </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> patients, no microsatellite instability was detected in the <z:hpo ids='HP_0011010'>chronic</z:hpo> phase, whereas a relatively high frequency (25%) of multiple microsatellite changes was evident in the <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blastic phase</z:e>, and half of these patients had multiple microsatellite changes </plain></SENT>
<SENT sid="5" pm="."><plain>About 50% of the patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and post-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (post-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) had microsatellite alterations </plain></SENT>
<SENT sid="6" pm="."><plain>We next compared microsatellite alterations in two different hematological phases (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and post-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> phases); 5 of 11 patients with post-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> had de novo appearance of microsatellite instability during disease progression </plain></SENT>
<SENT sid="7" pm="."><plain>This indicates that genomic instability at multiple microsatellite loci could occur either before or after leukemic transformation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="8" pm="."><plain>We concluded that genomic instability in <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> might be linked to blastic transformation in combination with cytogenetic changes </plain></SENT>
<SENT sid="9" pm="."><plain>In contrast, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients had replication errors as a relatively early genetic event as well as a late genetic event </plain></SENT>
<SENT sid="10" pm="."><plain>These results suggest that the involvement of genomic instability in the progression of disease is different among various types of <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>